Evaluating Bilateral Thoracoscopic Sympathectomy for Primary Focal Hyperhidrosis Treatment and Its Effects on Heart and Lung Function

What this Trial Is About

This research aims to evaluate the overall effectiveness of Bilateral Thoracoscopic Sympathectomy BTS for people with Primary Focal Hyperhidrosis, a condition causing excessive sweating on the palms, armpits, face, and soles. The study also looks at how BTS affects heart and lung function, the occurrence and severity of compensatory sweating, postoperative pain, complications, and quality of life for those with this condition. Participants will undergo BTS surgery with general anesthesia, where the sympathetic nerve chain is cut at different levels in the chest depending on group assignment. The groups include transection between thoracic ganglia T2-T4, T3-T4, or T2-T3. This is a prospective clinical study involving patients treated at Sohag University Hospital. During the study, participants will complete questionnaires before and after surgery to assess sweating severity, quality of life, pain levels, and compensatory sweating for up to three months. Heart and lung function tests will also be monitored. The main outcome is reduction of sweating severity immediately after surgery, with follow-up assessments to evaluate lasting effects and safety. Total participation lasts through the postoperative recovery and monitoring period.

Outcome Of Bilateral Thoracoscopic Sympathectomy for Patients With Primary Focal Hyperhidrosis